Limitations, agreements, and source contact

Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma · Source last updated 2026-03-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

GT60

restrictive Agreement

true

limitations And Caveats

description

Phase 2 was not started and therefore no planned Phase 2 endpoints were available for analysis.

point Of Contact

email

clinicaltrials@autolus.com

organization

Autolus Ltd

phone

+44 1483 920748

title

Clinical Project Manager

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice